TLR4 and metabolic dysfunction-associated steatotic liver disease: These findings are consistent with a reduction in TLR4 expression observed mainly in the high-adhered group, suggesting that MedDiet compounds can contribute to reducing the prooxidative and proinflammatory states present in NAFLD patients.